{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:21:43Z","timestamp":1762341703220,"version":"build-2065373602"},"reference-count":97,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T00:00:00Z","timestamp":1628380800000},"content-version":"unspecified","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dalhousie University Faculty of Medicine","award":["Killam Scholarship, Clinician Investigator Program"],"award-info":[{"award-number":["Killam Scholarship, Clinician Investigator Program"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["CDF-2016-09-014","DRF-2018-11-ST2-016"],"award-info":[{"award-number":["CDF-2016-09-014","DRF-2018-11-ST2-016"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dalhousie University Internal Medicine Research Foundation","award":["Internal Fellowship"],"award-info":[{"award-number":["Internal Fellowship"]}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN# 171259"],"award-info":[{"award-number":["FRN# 171259"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R25DA033211"],"award-info":[{"award-number":["R25DA033211"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2021,7,26]]},"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Injecting-related bacterial and fungal infections are a common complication among people who inject drugs (PWID), associated with significant morbidity and mortality. Invasive infections, including infective endocarditis, appear to be increasing in incidence. To date, preventive efforts have focused on modifying individual-level risk behaviours (eg, hand-washing and skin-cleaning) without much success in reducing the population-level impact of these infections. Learning from successes in HIV prevention, there may be great value in looking beyond individual-level risk behaviours to the social determinants of health. Specifically, the risk environment conceptual framework identifies how social, physical, economic and political environmental factors facilitate and constrain individual behaviour, and therefore influence health outcomes. Understanding the social and structural determinants of injecting-related bacterial and fungal infections could help to identify new targets for prevention efforts in the face of increasing incidence of severe disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This is a protocol for a systematic review. We will review studies of PWID and investigate associations between risk factors (both individual-level and social\/structural-level) and the incidence of hospitalisation or death due to injecting-related bacterial infections (skin and soft-tissue infections, bacteraemia, infective endocarditis, osteomyelitis, septic arthritis, epidural abscess and others). We will include quantitative, qualitative and mixed methods studies. Using directed content analysis, we will code risk factors for these infection-related outcomes according to their contributions to the risk environment in type (social, physical, economic or political) and level (microenvironmental or macroenvironmental). We will also code and present risk factors at each stage in the process of drug acquisition, preparation, injection, superficial infection care, severe infection care or hospitalisation, and outcomes after infection or hospital discharge.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>As an analysis of the published literature, no ethics approval is required. The findings will inform a research agenda to develop and implement social\/structural interventions aimed at reducing the burden of disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42021231411.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-049924","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T14:01:01Z","timestamp":1628517661000},"page":"e049924","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Social and structural determinants of injecting-related bacterial and fungal infections among people who inject drugs: protocol for a mixed studies systematic review"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5570-5556","authenticated-orcid":false,"given":"Thomas D","family":"Brothers","sequence":"first","affiliation":[{"name":"UCL Collaborative Centre for Inclusion Health, Institue of Epidemiology and Health Care, University College London, London, UK"},{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3698-7196","authenticated-orcid":false,"given":"Dan","family":"Lewer","sequence":"additional","affiliation":[{"name":"UCL Collaborative Centre for Inclusion Health, Institue of Epidemiology and Health Care, University College London, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-0171","authenticated-orcid":false,"given":"Matthew","family":"Bonn","sequence":"additional","affiliation":[{"name":"Canadian Association of People Who Use Drugs, Dartmouth, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-7150","authenticated-orcid":false,"given":"Duncan","family":"Webster","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"},{"name":"Division of Infectious Diseases, Saint John Regional Hospital, Saint John, New Brunswick, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-8226","authenticated-orcid":false,"given":"Magdalena","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"2025101812264452000_11.8.e049924.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.11.029"},{"key":"2025101812264452000_11.8.e049924.2","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/add.15283","article-title":"Injecting drug use, the skin and vasculature","volume":"116","author":"Robertson","year":"2021","journal-title":"Addiction"},{"key":"2025101812264452000_11.8.e049924.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-018-0243-9","article-title":"A pragmatic harm reduction approach to manage a large outbreak of wound botulism in people who inject drugs, Scotland 2015","volume":"15","author":"Trayner","year":"2018","journal-title":"Harm Reduct J"},{"key":"2025101812264452000_11.8.e049924.4","doi-asserted-by":"crossref","DOI":"10.7326\/M18-3026","article-title":"Drug-Associated infective endocarditis trends: what\"s all the buzz about?","volume":"170","author":"Wurcel","year":"2019","journal-title":"Ann Intern Med"},{"key":"2025101812264452000_11.8.e049924.5","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/01.blo.0000534682.68856.d8","article-title":"Increased mortality and reoperation rates after treatment for septic arthritis of the knee in people who inject drugs: nationwide inpatient sample, 2000-2013","volume":"476","author":"Oh","year":"2018","journal-title":"Clin Orthop Relat Res"},{"key":"2025101812264452000_11.8.e049924.6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/cid\/ciz804","article-title":"Infectious complications of addiction: a call for a new subspecialty within infectious diseases","volume":"70","author":"Serota","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025101812264452000_11.8.e049924.7","doi-asserted-by":"publisher","DOI":"10.1111\/add.14892"},{"key":"2025101812264452000_11.8.e049924.8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108057","article-title":"Incidence and treatment costs of severe bacterial infections among people who inject heroin: a cohort study in South London, England","volume":"212","author":"Lewer","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2025101812264452000_11.8.e049924.9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235350","article-title":"Prevalence and severity of abscesses and cellulitis, and their associations with other health outcomes, in a community-based study of people who inject drugs in London, UK","volume":"15","author":"Wright","year":"2020","journal-title":"PLoS One"},{"key":"2025101812264452000_11.8.e049924.10","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.180694"},{"key":"2025101812264452000_11.8.e049924.11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/CXA.0000000000000053","article-title":"Rates of infective endocarditis in substance use disorder and associated costs in Ontario","volume":"10","author":"Coverdale","year":"2019","journal-title":"Can J Addict"},{"key":"2025101812264452000_11.8.e049924.12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cjco.2020.05.002","article-title":"Epidemiology, microbiology, and clinical outcomes among patients with intravenous drug use-associated infective endocarditis in new Brunswick","volume":"2","author":"Mosseler","year":"2020","journal-title":"CJC Open"},{"key":"2025101812264452000_11.8.e049924.13","doi-asserted-by":"crossref","unstructured":"Lewer D , Harris M , Hope V . Opiate Injection\u2013Associated skin, soft tissue, and vascular infections, England, UK, 1997\u20132016. Emerg Infect Dis 2019:1400\u20133.","DOI":"10.3201\/eid2308.170439"},{"key":"2025101812264452000_11.8.e049924.14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/clc.23162","article-title":"Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact","volume":"42","author":"Bates","year":"2019","journal-title":"Clin Cardiol"},{"key":"2025101812264452000_11.8.e049924.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.011"},{"key":"2025101812264452000_11.8.e049924.16","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6622a1"},{"key":"2025101812264452000_11.8.e049924.17","doi-asserted-by":"publisher","DOI":"10.7326\/M18-2124"},{"key":"2025101812264452000_11.8.e049924.18","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw157"},{"key":"2025101812264452000_11.8.e049924.19","article-title":"Long-Term infective endocarditis mortality associated with injection opioid use in the United States: a modeling study","author":"Barocas","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025101812264452000_11.8.e049924.20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.hlc.2017.03.166","article-title":"The current epidemiology of injecting drug Use-Associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use","volume":"27","author":"Wright","year":"2018","journal-title":"Heart Lung Circ"},{"key":"2025101812264452000_11.8.e049924.21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005617","article-title":"Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: experience from a Swedish referral hospital","volume":"95","author":"Asgeirsson","year":"2016","journal-title":"Medicine"},{"key":"2025101812264452000_11.8.e049924.22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra042823"},{"key":"2025101812264452000_11.8.e049924.23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugalcdep.2008.08.016","article-title":"Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users","volume":"100","author":"Dwyer","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"2025101812264452000_11.8.e049924.24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.drugpo.2013.11.012","article-title":"Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities","volume":"25","author":"Hope","year":"2014","journal-title":"Int J Drug Policy"},{"key":"2025101812264452000_11.8.e049924.25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00952991003592311","article-title":"Risk practices associated with bacterial infections among injection drug users in Denver, Colorado","volume":"36","author":"Phillips","year":"2010","journal-title":"Am J Drug Alcohol Abuse"},{"key":"2025101812264452000_11.8.e049924.26","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102992","article-title":"Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study","volume":"87","author":"Roux","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2025101812264452000_11.8.e049924.27","doi-asserted-by":"publisher","DOI":"10.1111\/add.15236"},{"key":"2025101812264452000_11.8.e049924.28","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000001294"},{"key":"2025101812264452000_11.8.e049924.29","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304187"},{"key":"2025101812264452000_11.8.e049924.30","doi-asserted-by":"crossref","unstructured":"Okechukwu C , Davison K , Emmons K . Changing Health Behaviors in a Social Context. In: Berkman LF , Kawachi I , Glymour MM , eds. Social epidemiology. Oxford University Press, 2014: 365\u201395.","DOI":"10.1093\/med\/9780195377903.003.0010"},{"key":"2025101812264452000_11.8.e049924.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.08.044"},{"key":"2025101812264452000_11.8.e049924.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31959-1"},{"key":"2025101812264452000_11.8.e049924.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60743-X"},{"key":"2025101812264452000_11.8.e049924.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-3959(02)00007-5"},{"key":"2025101812264452000_11.8.e049924.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2008.10.003"},{"key":"2025101812264452000_11.8.e049924.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2004.12.024"},{"key":"2025101812264452000_11.8.e049924.37","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112384","article-title":"The intersectional risk environment of people who use drugs","volume":"234","author":"Collins","year":"2019","journal-title":"Soc Sci Med"},{"key":"2025101812264452000_11.8.e049924.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7510.220"},{"key":"2025101812264452000_11.8.e049924.39","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-10-7"},{"key":"2025101812264452000_11.8.e049924.40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.drugpo.2016.01.009","article-title":"\"There\"s nothing here\": Deindustrialization as risk environment for overdose","volume":"29","author":"McLean","year":"2016","journal-title":"Int J Drug Policy"},{"key":"2025101812264452000_11.8.e049924.41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.socscimed.2014.01.051","article-title":"\"Safer environment interventions\": a qualitative synthesis of the experiences and perceptions of people who inject drugs","volume":"106","author":"McNeil","year":"2014","journal-title":"Soc Sci Med"},{"key":"2025101812264452000_11.8.e049924.42","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00369-0"},{"key":"2025101812264452000_11.8.e049924.43","unstructured":"Unsigned. Heart infection projected to kill one in five people who inject opioids by 2030. Filter, 2020. Available: https:\/\/filtermag.org\/opioids-endocarditis-deaths\/ [Accessed 9 Dec 2020]."},{"key":"2025101812264452000_11.8.e049924.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113183"},{"key":"2025101812264452000_11.8.e049924.45","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0390-3"},{"key":"2025101812264452000_11.8.e049924.46","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-005-9007-4"},{"key":"2025101812264452000_11.8.e049924.47","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1"},{"key":"2025101812264452000_11.8.e049924.48","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2025101812264452000_11.8.e049924.49","first-page":"163","article-title":"Conducting systematic reviews of association (etiology): The Joanna Briggs Institute\u2019s approach","volume":"13","author":"Moola","year":"2015","journal-title":"JBI Evid Implement"},{"key":"2025101812264452000_11.8.e049924.50","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-032013-182440"},{"key":"2025101812264452000_11.8.e049924.51","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jclinepi.2015.08.033","article-title":"Opening-up the definition of systematic literature review: the plurality of worldviews, methodologies and methods for reviews and syntheses","volume":"73","author":"Pluye","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025101812264452000_11.8.e049924.52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jclinepi.2015.12.011","article-title":"Knowledge synthesis methods for integrating qualitative and quantitative data: a scoping review reveals poor operationalization of the methodological steps","volume":"73","author":"Tricco","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2025101812264452000_11.8.e049924.53","doi-asserted-by":"publisher","DOI":"10.1258\/1355819052801804"},{"key":"2025101812264452000_11.8.e049924.54","doi-asserted-by":"crossref","unstructured":"Heyvaert M , Hannes K , Onghena P . Using mixed methods research synthesis for literature reviews: the mixed methods research synthesis approach. SAGE Publications, 2016.","DOI":"10.4135\/9781506333243"},{"key":"2025101812264452000_11.8.e049924.55","doi-asserted-by":"publisher","DOI":"10.1111\/jan.12000"},{"key":"2025101812264452000_11.8.e049924.56","doi-asserted-by":"crossref","unstructured":"Rhodes T , Wagner K , Strathdee SA . Structural Violence and Structural Vulnerability Within the Risk Environment: Theoretical and Methodological Perspectives for a Social Epidemiology of HIV Risk Among Injection Drug Users and Sex Workers. In: O\u2019Campo P , Dunn JR , eds. Rethinking social epidemiology: towards a science of change. Dordrecht: Springer Netherlands, 2012: 205\u201330.","DOI":"10.1007\/978-94-007-2138-8_10"},{"key":"2025101812264452000_11.8.e049924.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.10.004"},{"key":"2025101812264452000_11.8.e049924.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.03.009"},{"key":"2025101812264452000_11.8.e049924.59","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq441"},{"key":"2025101812264452000_11.8.e049924.60","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.3.30446","article-title":"Ongoing outbreak of invasive and non-invasive disease due to group A Streptococcus (gas) type emm66 among homeless and people who inject drugs in England and Wales, January to December 2016","volume":"22","author":"Bundle","year":"2017","journal-title":"Euro Surveill"},{"key":"2025101812264452000_11.8.e049924.61","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3201\/eid2603.191408","article-title":"Methicillin-Resistant Staphylococcus aureus Bloodstream Infections and Injection Drug Use, Tennessee, USA, 2015\u20132017","volume":"26","author":"Parikh","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2025101812264452000_11.8.e049924.62","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38636.593461.68"},{"key":"2025101812264452000_11.8.e049924.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2009.08.003"},{"key":"2025101812264452000_11.8.e049924.64","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835221cc"},{"key":"2025101812264452000_11.8.e049924.65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/epirev\/mxaa008","article-title":"Prevalence and correlates of providing and receiving assistance with the transition to injection drug use","volume":"42","author":"Gicquelais","year":"2020","journal-title":"Epidemiol Rev"},{"key":"2025101812264452000_11.8.e049924.66","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-035188"},{"key":"2025101812264452000_11.8.e049924.67","unstructured":"Kudrina I , Puzhko S , Filion KB . Effectiveness of interventions for prevention of common infections in people who use opioids: a protocol for a systematic review of systematic reviews (Preprint). ResearchSquare."},{"key":"2025101812264452000_11.8.e049924.68","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-020-00378-z","article-title":"Risk factors of infective endocarditis in persons who inject drugs","volume":"17","author":"Shah","year":"2020","journal-title":"Harm Reduct J"},{"key":"2025101812264452000_11.8.e049924.69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(19)30705-4","article-title":"Hydromorphone and the risk of infective endocarditis among people who inject drugs: a population-based, retrospective cohort study","volume":"20","author":"Silverman","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025101812264452000_11.8.e049924.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.04.009"},{"key":"2025101812264452000_11.8.e049924.71","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0330-6"},{"key":"2025101812264452000_11.8.e049924.72","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/add.13898","article-title":"Assessing the impact of a temporary class drug order on ethylphenidate-related infections among people who inject drugs in Lothian, Scotland: an interrupted time-series analysis","volume":"112","author":"Yeung","year":"2017","journal-title":"Addiction"},{"key":"2025101812264452000_11.8.e049924.73","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102663","article-title":"Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs","volume":"77","author":"Trayner","year":"2020","journal-title":"Int J Drug Policy"},{"key":"2025101812264452000_11.8.e049924.74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/EFI-180221","article-title":"The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong","year":"2018","journal-title":"EFI"},{"key":"2025101812264452000_11.8.e049924.75","doi-asserted-by":"publisher","DOI":"10.1177\/1558689818770058"},{"key":"2025101812264452000_11.8.e049924.76","doi-asserted-by":"publisher","DOI":"10.1177\/1049732305276687"},{"key":"2025101812264452000_11.8.e049924.77","doi-asserted-by":"crossref","unstructured":"Deeks JJ , Higgins JP , Altman DG . Analysing data and undertaking meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions. John Wiley & Sons, Ltd, 2019: 241\u201384.","DOI":"10.1002\/9781119536604.ch10"},{"key":"2025101812264452000_11.8.e049924.78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002680"},{"key":"2025101812264452000_11.8.e049924.79","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15288\/jsad.2020.81.556","article-title":"Addressing the Syndemic of HIV, hepatitis C, overdose, and COVID-19 among people who use drugs: the potential roles for decriminalization and safe supply","volume":"81","author":"Bonn","year":"2020","journal-title":"J Stud Alcohol Drugs"},{"key":"2025101812264452000_11.8.e049924.80","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190430"},{"key":"2025101812264452000_11.8.e049924.81","unstructured":"Bonn M , Touesnard N , Cheng B . Barriers and facilitators to accessing and providing a safe supply of drugs during COVID-19 and beyond: a scoping review. Submitted."},{"key":"2025101812264452000_11.8.e049924.82","first-page":"1-8","article-title":"Implementation and evaluation of a novel, unofficial, trainee-organized Hospital addiction medicine consultation service","author":"Brothers","year":"2020","journal-title":"Subst Abus"},{"key":"2025101812264452000_11.8.e049924.83","unstructured":"Brothers TD , Webster D . Multidisciplinary infective endocarditis care teams should address substance use disorders and harm reduction services. Open Heart 2018;4 https:\/\/openheart.bmj.com\/content\/4\/2\/e000699.responses#multidisciplinary-infective-endocarditis-care-teams-should-address-substance-use-disorders-and-harm-reduction-services"},{"key":"2025101812264452000_11.8.e049924.84","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.202124"},{"key":"2025101812264452000_11.8.e049924.85","doi-asserted-by":"crossref","first-page":"540423","DOI":"10.3389\/fpubh.2020.540423","article-title":"The Opioid\/Overdose crisis as a Dialectics of pain, despair, and one-sided struggle","volume":"8","author":"Friedman","year":"2020","journal-title":"Front Public Health"},{"key":"2025101812264452000_11.8.e049924.86","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.22374\/jmhan.v3i1.33","article-title":"Sowing a seed of safety: providing culturally safe care in acute care settings for people who use drugs","volume":"3","author":"McCall","year":"2019","journal-title":"JMHAN"},{"key":"2025101812264452000_11.8.e049924.87","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103324","article-title":"Hospital policy as a harm reduction intervention for people who use drugs","volume":"97","author":"Lennox","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2025101812264452000_11.8.e049924.88","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268820001260","article-title":"Numerous outbreaks amongst homeless and injection drug-using populations raise concerns of an evolving syndemic in London, Canada","volume":"148","author":"Turner","year":"2020","journal-title":"Epidemiol Infect"},{"key":"2025101812264452000_11.8.e049924.89","unstructured":"Tiako MJN , Mszar R , Brooks C . Cardiac surgeons\u2019 treatment approaches for infective endocarditis based on patients\u2019 substance use history. Semin Thorac Cardiovasc Surg 2020."},{"key":"2025101812264452000_11.8.e049924.90","unstructured":"KR A , JGY L , Tam DY . Infective endocarditis secondary to injection drug use: a survey of Canadian cardiac surgeons. Ann Thorac Surg 2020."},{"key":"2025101812264452000_11.8.e049924.91","first-page":"1416","article-title":"Making the cut: perspectives on the surgical management of infective endocarditis among people who use intravenous drugs","volume":"35","author":"Buchanan","year":"2019","journal-title":"Can J Cardiol"},{"key":"2025101812264452000_11.8.e049924.92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03749.x"},{"key":"2025101812264452000_11.8.e049924.93","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0955-3959(98)00062-0","article-title":"Networks and HIV risk: an introduction to social network analysis for harm reductionists","volume":"9","author":"Friedman","year":"1998","journal-title":"Int J Drug Policy"},{"key":"2025101812264452000_11.8.e049924.94","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01596-07"},{"key":"2025101812264452000_11.8.e049924.95","doi-asserted-by":"publisher","DOI":"10.1086\/383471"},{"key":"2025101812264452000_11.8.e049924.96","doi-asserted-by":"publisher","DOI":"10.3201\/eid1808.111343"},{"key":"2025101812264452000_11.8.e049924.97","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/jamia\/ocaa175","article-title":"A call for social informatics","volume":"27","author":"Pantell","year":"2020","journal-title":"J Am Med Inform Assoc"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-049924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T19:26:58Z","timestamp":1760815618000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-049924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":97,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,9]]},"published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1136\/bmjopen-2021-049924"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-049924","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"type":"print","value":"2044-6055"},{"type":"electronic","value":"2044-6055"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}